Publications

Alternative Molecular Methods for Improved Detection of Meningococcal Carriage and Measurement of Bacterial Density.

MANIGART, O; Okeakpu, J; ODUTOLA, A; JARJU, S; FOSTER-NYARKO, E; Diallo, K; ROCA, A; KAMPMANN, B; D'ALESSANDRO, U; Sow, S; ANTONIO, M; Maiden, MJ; Borrow, R; Stuart, JM; Trotter, CL; GREENWOOD, BM;

2016

Journal of clinical microbiology, (2016).54 11 10.1128/JCM.01428-16.

Changes in the primary outcome in Ebola vaccine trial--Authors' reply.

Kieny, MP; Longini, IM; Henao-Restrepo, AM; WATSON, CH; Egger, M; EDMUNDS, WJ;

2016

Lancet, (2016).387 10027 10.1016/S0140-6736(16)00686-3.

Why the Convention on the Rights of the Child must become a guiding framework for the realization of the rights of children affected by tuberculosis.

BASU ROY, R; Brandt, N; Moodie, N; Motlagh, M; Rasanathan, K; Seddon, JA; Detjen, AK; KAMPMANN, B;

2016

BMC INTERNATIONAL HEALTH AND HUMAN RIGHTS, (2016).16 1 10.1186/s12914-016-0105-z.

Vaccine hesitancy among healthcare workers in Europe: A qualitative study.

KARAFILLAKIS, E; Dinca, I; Apfel, F; Cecconi, S; Wűrz, A; Takacs, J; Suk, J; Celentano, LP; Kramarz, P; LARSON, HJ;

2016

Vaccine, (2016).34 41 10.1016/j.vaccine.2016.08.029.

A hepatitis-free future: strategy first, then pricing.

LARSON, HJ; Van Damme, P; FitzSimons, D;

2016

The Lancet infectious diseases, (2016).16 4 10.1016/S1473-3099(16)00126-2.

First data in African subjects for the monovalent Janssen Ebola Zaire heterologous prime-boost vaccines, combining Ad26.ZEBOV and MVA-BN-Filo.

Anzala, O; Mutua, G; Nyaoke, B; Robinson, C; Luhn, K; Callendret, B; Thiebaut, R; Snape, M; WATSON-JONES, D; Douoguih, M;

2016

International Journal of Infectious Diseases, (2016).53, 10.1016/j.ijid.2016.11.080.

Forecasted trends in vaccination coverage and correlations with socioeconomic factors: a global time-series analysis over 30 years.

DE FIGUEIREDO, A; Johnston, IG; SMITH, DM D; Agarwal, S; LARSON, HJ; Jones, NS;

2016

The Lancet Global health, (2016).4 10 10.1016/S2214-109X(16)30167-X.

Erratum to: B cell sub-types following acute malaria and associations with clinical immunity.

Sullivan, RT; SSEWANYANA, I; Wamala, S; Nankya, F; Jagannathan, P; Tappero, JW; Mayanja-Kizza, H; Muhindo, MK; ARINAITWE, E; Kamya, M; Dorsey, G; Feeney, ME; RILEY, EM; DRAKELEY, CJ; Greenhouse, B;

2016

Malaria journal, (2016).15 1 10.1186/s12936-016-1236-3.

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.

FLASCHE, S; JIT, M; Rodríguez-Barraquer, I; Coudeville, L; Recker, M; Koelle, K; Milne, G; Hladish, TJ; Perkins, TA; Cummings, DA T; Dorigatti, I; Laydon, DJ; España, G; Kelso, J; Longini, I; Lourenco, J; PEARSON, CA B; Reiner, RC; Mier-Y-Terán-Romero, L; Vannice, K; Ferguson, N;

2016

PLoS medicine, (2016).13 11 10.1371/journal.pmed.1002181.

Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system.

Loganathan, T; JIT, M; Hutubessy, R; Ng, C-W; Lee, W-S; Verguet, S;

2016

Tropical medicine & international health, (2016).21 11 10.1111/tmi.12766.